Clinical Trial Update: Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating 5-fluorouracil for metastatic colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)

Snippet

Sponsor: Inova Health Care Services | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: WITHDRAWN